GO and KEGG enrichment analyses demonstrated that these DEGs were primarily enriched in cytokine- and chemokine-related pathways, suggesting a potential role of the BRAF V600E mutation in modulating tumor immunity (Fig. 3F, G). This evidence concerns the gene BRAF and neoplasm.